Abstract
Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by severe joint pain. There are conflicting results for the association of Interleukin 4 (IL4) variable number tandem repeats (VNTR; rs8179190) polymorphism with RA. Therefore, we performed a meta-analysis of the available studies to investigate the association of IL4 VNTR polymorphism with RA risk and severity in the overall populations and Asian, Egyptian, European, and Turkish ethnicities by sub-group analyses. Eight studies involving 1993 RA patients and 1732 controls were included in this meta-analysis. We found increased RA risk for the susceptible “R2R2” genotype and “R2” allele under heterozygous, recessive, and allelic models in the Asian populations (p < 0.00001, p < 0.0001, p = 0.001). We observed a significant association between “R2R2” genotype and “R2” allele for RA protection in the Turkish population under heterozygous, recessive, and allelic models (p = 0.01, p = 0.004, p = 0.002). Disease severity-based analysis revealed significant association for “R2R2” genotype and “R2” allele with RA severity under homozygous, heterozygous, recessive, dominant, and allelic models(p = 0.0004, p = 0.03, p = 0.02, p = 0.003, p = 0.01), specifically in Asian populations (p = 0.009, p = 0.02, p = 0.003, p = 0.03, p = 0.01) and under heterozygous, dominant, and allelic genetic models in Egyptian (p = 0.0001, p < 0.0001, p < 0.0001) and European (p = 0.002, p = 0.0007, p = 0.0006) populations. In silico analysis suggested that the susceptible “R2” allele changes the RNA secondary structure to a stable form by changing minimum free energy(ΔG) from − 115.20 to − 136.40 kcal/mol, which might lead to increased stability of IL-4 in RA patients. Overall, the meta-analysis suggests for the involvement of susceptible “R2” allele with RA risk in the Asian populations, RA severity in the overall populations (specifically in Asian, Egyptian, & European populations), and RA protection in the Turkish population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Data are available within the article.
References
Al Barzinji RMGT, Raheem SG, Khudhur PK, Abdulkarimi R, Mohammadnejad E, Tabatabaee A, Abdulkareem NK (2020) Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length. Cell Mol Biol 66:15–18. https://doi.org/10.14715/CMB/2020.66.6.3
Balce DR, Li B, Allan ERO, Rybicka JM, Krohn RM, Yates RM (2011) Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms. Blood 118:4199–4208. https://doi.org/10.1182/blood-2011-01-328906
Barton A, Worthington J (2009) Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis Rheum 61:1441–1446. https://doi.org/10.1002/art.24672
Beh-Pajooh A, Fasihi-Ramandi M, Tavallaie M (2017) Association analysis of IL-4 VNTR polymorphism with rheumatoid arthritis in Iranian patients. Russ J Genet 53:406–409. https://doi.org/10.1134/S1022795417030036
Buchs N, Silvestri T, Di Giovine FS, Chabaud M, Vannier E, Duff GW, Miossec P (2000) IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology 39:1126–1131. https://doi.org/10.1093/rheumatology/39.10.1126
Cantagrel A, Navaux F, Loubet-Lescoulié P, Nourhashemi F, Enault G, Abbal M, Constantin A, Laroche M, Mazières B (1999) Interleukin-1β, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42:1093–1100. https://doi.org/10.1002/1529-0131(199906)42:6%3c1093::AID-ANR5%3e3.0.CO;2-P
Chen Z, Bozec A, Ramming A, Schett G (2019) Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol 15:9–17. https://doi.org/10.1038/s41584-018-0109-2
Cicuttini FM, Spector TD (1995) Osteoarthritis in the aged: epidemiological issues and optimal management. Drugs Aging 6:409–420. https://doi.org/10.2165/00002512-199506050-00007
Dar SA, Haque S, Mandal RK, Singh T, Wahid M, Jawed A, Panda AK, Akhter N, Lohani M, Areeshi MY et al (2017) Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: a case-control study and meta-analysis. Autoimmunity 50:158–169. https://doi.org/10.1080/08916934.2016.1261833
Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM (2017) Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol 31:3–18. https://doi.org/10.1016/j.berh.2017.08.003
Dedmon LE (2020) The genetics of rheumatoid arthritis. Rheumatology. https://doi.org/10.1093/rheumatology/keaa232
Del Prete G, Maggi E, Parronchi P, Chrétien I, Tiri A, Macchia D, Ricci M, Banchereau J, De Vries J, Romagnani S (1988) IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 140:4193–4198
Duan Y, Pan C, Shi J, Chen H, Zhang S (2014) Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk. Cancer Cell Int 14:1–8. https://doi.org/10.1186/S12935-014-0131-7/FIGURES/4
Elghoroury EA, Fadel FI, Farouk H, Elshamaa MF, Kamel S, Kandil D, Mahmoud E (2018) Association of variable number tandem repeats polymorphism in the IL-4 gene with end-stage renal disease in children. Egypt J Med Hum Genet 19:191–195. https://doi.org/10.1016/J.EJMHG.2017.08.009
Elshazli R, Settin A, Salama A (2015) Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) +49 A>G gene polymorphism in Egyptian cases with rheumatoid arthritis. Gene 558:103–107. https://doi.org/10.1016/j.gene.2014.12.046
Elshazli R, Elsaid AM, Shawky DM, Barakat LAA (2019) Genetic polymorphisms of ACE I/D, IL-1β G > A and IL-4 VNTR among Egyptian subjects with rheumatoid arthritis. Arch Physiol Biochem. https://doi.org/10.1080/13813455.2019.1703005
Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191
Genevay S, Di Giovine FS, Perneger TV, Silvestri T, Stingelin S, Duff G, Guerne P-A (2002) Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum 47:303–309. https://doi.org/10.1002/art.10394
Giri P, Begum R, Dwivedi M (2021a) Meta-analysis for association of TNFA -308 G>a polymorphism with vitiligo susceptibility. Gene 809:146027. https://doi.org/10.1016/j.gene.2021.146027
Giri P, Shah F, Gupta B, Dhangar A, Pathak VN, Desai B, Dwivedi M (2021b) Genetic association of interleukin-4 VNTR polymorphism with susceptibility to rheumatoid arthritis in South Gujarat population. Gene Reports 25:101322
Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH (2002) Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31:355–360. https://doi.org/10.1053/sarh.2002.32552
Granato A, Hayashi EA, Baptista BJA, Bellio M, Nobrega A (2014) IL-4 regulates bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints. J Immunol 192:5761–5775. https://doi.org/10.4049/jimmunol.1300749
Gruber AR, Lorenz R, Bernhart SH, Neuböck R, Hofacker IL (2008) The Vienna RNA Websuite. Nucleic Acids Res 36:W70–W74. https://doi.org/10.1093/nar/gkn188
Han H, Dawson K (2020). JASP (software). https://doi.org/10.31234/osf.io/67dcb
Hua X, Chason KD, Patel JY, Naselsky WC, Tilley SL (2011) IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors. PLoS ONE 6:e24947. https://doi.org/10.1371/journal.pone.0024947
Hussein YM, El-Shal AS, Rezk NA, Abdel Galil SM, Alzahrani SS (2013) Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population. Cytokine 61:849–855. https://doi.org/10.1016/j.cyto.2013.01.001
Imran M, Laddha NC, Dwivedi M, Mansuri MS, Singh J, Rani R, Gokhale RS, Sharma VK, Marfatia YS, Begum R (2012) Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Br J Dermatol 167:314–323. https://doi.org/10.1111/j.1365-2133.2012.11000.x
Inanir A, Yigit S, Tekcan A, Tural S, Kismali G (2013) IL-4 and MTHFR gene polymorphism in rheumatoid arthritis and their effects. Immunol Lett 152:104–108. https://doi.org/10.1016/j.imlet.2013.05.004
Ishida H, Ota H, Yanagida H, Dobashi H (1997) An imbalance between Th1 and Th2-like cytokines in patients with autoimmune diseases–differential diagnosis between Th1 dominant autoimmune diseases and Th2 dominant autoimmune diseases. Nihon Rinsho 55:1438–1443
Kidd P (2003) Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 8:223–246
Kurkó J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z (2013) Genetics of rheumatoid arthritis - a comprehensive review. Clin Rev Allergy Immunol 45:170–179. https://doi.org/10.1007/s12016-012-8346-7
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. https://doi.org/10.1136/bmj.b2700
Lin L, Chu H (2018) Quantifying publication bias in meta-analysis. Biometrics 74:785–794. https://doi.org/10.1111/biom.12817
MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43:30–37. https://doi.org/10.1002/1529-0131(200001)43:1%3c30::AID-ANR5%3e3.0.CO;2-B
Mak TW, Saunders ME (2006) Cytokines and cytokine receptors. The immune response. Elsevier, Amsterdam, pp 463–516
Mohammadoo-Khorasani M, Salimi S, Tabatabai E, Sandoughi M, Zakeri Z, Farajian-Mashhadi F (2016) Interleukin-1β (IL-1β) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE. Indian J Med Res 143:591–596. https://doi.org/10.4103/0971-5916.187107
Nakashima H, Miyake K, Inoue Y, Shimizu S, Akahoshi M, Tanaka Y, Otsuka T, Harada M (2002) Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 3:107–109. https://doi.org/10.1038/sj.gene.6363830
Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S et al (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:376–381. https://doi.org/10.1038/nature12873
Park HK, Kim SK, Kweon HY, Lee KG, Arasu MV, Kim YO (2017) Promoter polymorphism (-590, T/C) of interleukin 4 (IL4) gene is associated with rheumatoid arthritis: an updated meta-analysis. Saudi J Biol Sci 24:444–449. https://doi.org/10.1016/j.sjbs.2016.01.013
Pavlovic V, Dimic A, Milenkovic S, Krtinic D (2014) Serum levels of IL-17, IL-4, and INFγ in Serbian patients with early rheumatoid arthritis. J Res Med Sci 19:18–22
Peng L, Meng F, Liu Y, Zhang L (2020) Interleukin 8 association with respiratory syncytial virus bronchiolitis: a systematic review and meta-analysis. Cell Mol Biol 66:74–77
Ridgley LA, Anderson AE, Pratt AG (2018) What are the dominant cytokines in early rheumatoid arthritis? Curr Opin Rheumatol 30:207–214. https://doi.org/10.1097/BOR.0000000000000470
Rivas D, Mozo L, Zamorano J, Gayo A, Torre-Alonso JC, Rodriguez A, Gutiérrez C (1995) Upregulated expression of IL-4 receptors and increased levels of IL-4 in rheumatoid arthritis patients. J Autoimmun 8:587–600. https://doi.org/10.1016/0896-8411(95)90010-1
Robert F, Pelletier J (2018) Exploring the impact of single-nucleotide polymorphisms on translation. Front Genet 9:507. https://doi.org/10.3389/fgene.2018.00507
Salemi M, Barone C, Romano C, Salluzzo MG, Giambirtone M, Morale MC, Calogero AE, Grillo L, Bosco P, Romano C (2015) A peculiar VNTR in the cystathionine β-synthase gene is a risk factor for down syndrome. Cell Mol Biol (noisy-Le-Grand) 61:49–51
Shen Z, Li RZ, Prohaska TA, Hoeksema MA, Spann NJ, Tao J, Fonseca GJ, Le T, Stolze LK, Sakai M et al (2022) Systematic analysis of naturally occurring insertions and deletions that alter transcription factor spacing identifies tolerant and sensitive transcription factor pairs. Elife 11:e70878. https://doi.org/10.7554/eLife.70878
Strand V, Lee EB, Yazici Y, Dikranian A, Wilkinson B, Takiya L, Zang C, Bananis E, Bergman MJ (2018) Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials. Clin Rheumatol 37:2043–2053. https://doi.org/10.1007/s10067-018-4077-3
Thanapati S, Ganu M, Giri P, Kulkarni S, Sharma M, Babar P, Ganu A, Tripathy AS (2017) Impaired NK cell functionality and increased TNF-α production as biomarkers of chronic chikungunya arthritis and rheumatoid arthritis. Hum Immunol 78:370–374. https://doi.org/10.1016/j.humimm.2017.02.006
Wang M, Marín A (2006) Characterization and prediction of alternative splice sites. Gene 366:219–227. https://doi.org/10.1016/j.gene.2005.07.015
Zhang Y, Li W (2020) Effects of oral desloratadine citrate disodium combined with physiological seawater nasal irrigation on IgE levels, IL-4, IL-6, IL-13 and IFN-Î3 expression and treatment of intermittent allergic rhinitis. Cell Mol Biol 66:54–58. https://doi.org/10.14715/CMB/2020.66.5.11
Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406–3415. https://doi.org/10.1093/nar/gkg595
Acknowledgements
We thank Science & Engineering Research Board, Department of Science & Technology(SERB-DST), New Delhi, India for providing the research grant to Dr. Mitesh Dwivedi {ECR/2017/ 000858} and {CRG/2021/002419}. PSG thanks the SERB-DST, New Delhi, for awarding SRF and Knowledge Consortium of Gujarat, Education Department, Government of Gujarat, India, for awarding SHODH (Scheme of Developing High Quality Research) fellowship.
Funding
This work was supported by the Science & Engineering Research Board, Department of Science & Technology (SERB-DST), New Delhi, India under grant to Dr. Mitesh Dwivedi {ECR/2017/ 000858} and {CRG/2021/002419}.
Author information
Authors and Affiliations
Contributions
PSG contributed to investigation, methodology, validation, analysis, and writing and preparation of original draft. MD contributed to conceptualization, funding acquisition, investigation, methodology, resources, supervision, visualization, and writing, reviewing, & editing of the manuscript.
Corresponding author
Ethics declarations
Competing Interests
We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
Ethical Approval
Not applicable.
Consent to Participate
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Giri, P.S., Dwivedi, M. Meta-analysis for Association of Interleukin 4 VNTR Polymorphism with Rheumatoid Arthritis Risk and Severity. Biochem Genet 61, 823–846 (2023). https://doi.org/10.1007/s10528-022-10288-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-022-10288-3